RELAPSED HEMATOLOGIC MALIGNANCY
Clinical trials for RELAPSED HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new RELAPSED HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for RELAPSED HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo shows promise for tough brain cancer
Disease control Recruiting nowThis study tests an experimental oral drug called emavusertib (CA-4948), taken alone or with another drug (ibrutinib), in adults with a rare brain lymphoma that has returned or not responded to prior therapy. The goal is to find safe doses and see if the combination can shrink tu…
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated May 17, 2026 07:56 UTC
-
European experts unite to personalize cancer care for kids with relapsed leukemia
Knowledge-focused Recruiting nowThis study brings together a team of specialists across Europe to review each child's unique cancer genetics and recommend the most promising treatment from available options. It includes 600 children and young adults up to age 25 with relapsed or hard-to-treat blood cancers. The…
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Knowledge-focused
Last updated May 17, 2026 07:59 UTC